Cargando…
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
Colorectal cancer is a major health burden, and a leading cause of cancer-related deaths in industrialized countries. The steady improvements in surgery and chemotherapy have improved survival, but the ability to identify high- and low-risk patients is still somewhat poor. Molecular biology has, ove...
Autores principales: | Berg, Marianne, Søreide, Kjetil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257138/ https://www.ncbi.nlm.nih.gov/pubmed/22272141 http://dx.doi.org/10.3390/ijms12129426 |
Ejemplares similares
-
Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
por: Roalsø, Marcus T. T., et al.
Publicado: (2022) -
KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
por: Søreide, Kjetil, et al.
Publicado: (2014) -
Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients
por: Lind, Guro E., et al.
Publicado: (2017) -
Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
por: Veen, Torhild, et al.
Publicado: (2017) -
Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
por: Søreide, Kjetil, et al.
Publicado: (2016)